BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 30760204)

  • 1. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.
    O'Mahony D; Gudmundsson A; Soiza RL; Petrovic M; Cruz-Jentoft AJ; Cherubini A; Fordham R; Byrne S; Dahly D; Gallagher P; Lavan A; Curtin D; Dalton K; Cullinan S; Flanagan E; Shiely F; Samuelsson O; Sverrisdottir A; Subbarayan S; Vandaele L; Meireson E; Montero-Errasquin B; Rexach-Cano A; Correa Perez A; Lozano-Montoya I; Vélez-Díaz-Pallarés M; Cerenzia A; Corradi S; Soledad Cotorruelo Ferreiro M; Dimitri F; Marinelli P; Martelli G; Fong Soe Khioe R; Eustace J
    Age Ageing; 2020 Jul; 49(4):605-614. PubMed ID: 32484850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
    O'Mahony D
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):15-22. PubMed ID: 31790317
    [No Abstract]   [Full Text] [Related]  

  • 4. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.
    Crowley EK; Sallevelt BTGM; Huibers CJA; Murphy KD; Spruit M; Shen Z; Boland B; Spinewine A; Dalleur O; Moutzouri E; Löwe A; Feller M; Schwab N; Adam L; Wilting I; Knol W; Rodondi N; Byrne S; O'Mahony D
    BMC Health Serv Res; 2020 Mar; 20(1):220. PubMed ID: 32183810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial.
    O'Connor MN; O'Sullivan D; Gallagher PF; Eustace J; Byrne S; O'Mahony D
    J Am Geriatr Soc; 2016 Aug; 64(8):1558-66. PubMed ID: 27365262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial.
    Jungo KT; Rozsnyai Z; Mantelli S; Floriani C; Löwe AL; Lindemann F; Schwab N; Meier R; Elloumi L; Huibers CJA; Sallevelt BTGM; Meulendijk MC; Reeve E; Feller M; Schneider C; Bhend H; Bürki PM; Trelle S; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMJ Open; 2019 Sep; 9(9):e031080. PubMed ID: 31481568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing Adverse Drug Reactions After Hospital Discharge (PADR-AD): Protocol for a randomised-controlled trial in older people.
    Cousins J; Parameswaran Nair N; Curtain C; Bereznicki B; Wilson K; Adamczewski B; Barratt A; Webber L; Simpson T; McKenzie D; Connolly M; Bereznicki L
    Res Social Adm Pharm; 2022 Aug; 18(8):3284-3289. PubMed ID: 34593344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Adverse Drug Reactions in Hospitalised Older Patients Using a Software-Supported Structured Pharmacist Intervention: A Cluster Randomised Controlled Trial.
    O'Sullivan D; O'Mahony D; O'Connor MN; Gallagher P; Gallagher J; Cullinan S; O'Sullivan R; Eustace J; Byrne S
    Drugs Aging; 2016 Jan; 33(1):63-73. PubMed ID: 26597401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Affecting Prescriber Implementation of Computer-Generated Medication Recommendations in the SENATOR Trial: A Qualitative Study.
    Dalton K; O'Mahony D; Cullinan S; Byrne S
    Drugs Aging; 2020 Sep; 37(9):703-713. PubMed ID: 32681402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.
    Sallevelt BTGM; Huibers CJA; Heij JMJO; Egberts TCG; van Puijenbroek EP; Shen Z; Spruit MR; Jungo KT; Rodondi N; Dalleur O; Spinewine A; Jennings E; O'Mahony D; Wilting I; Knol W
    Drugs Aging; 2022 Jan; 39(1):59-73. PubMed ID: 34877629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to reduce prescribing errors in elderly patients with multimorbidity.
    Lavan AH; Gallagher PF; O'Mahony D
    Clin Interv Aging; 2016; 11():857-66. PubMed ID: 27382268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of hospital-acquired adverse drug reactions: a cohort of Ugandan older adults.
    Yadesa TM; Kitutu FE; Tamukong R; Alele PE
    BMC Geriatr; 2022 Apr; 22(1):359. PubMed ID: 35461224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study.
    Doherty AS; Boland F; Moriarty F; Fahey T; Wallace E
    Br J Gen Pract; 2023 Mar; 73(728):e211-e219. PubMed ID: 36823047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive-related adverse drug reactions among older hospitalized adults.
    Alhawassi TM; Krass I; Pont LG
    Int J Clin Pharm; 2018 Apr; 40(2):428-435. PubMed ID: 29392477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for a single-centre, prospective, non-blinded, randomised, 12-month, parallel-group superiority study to compare the efficacy of pharmacist intervention versus usual care for elderly patients hospitalised in orthopaedic wards.
    Komagamine J; Sugawara K; Kaminaga M; Tatsumi S
    BMJ Open; 2018 Jul; 8(7):e021924. PubMed ID: 30061440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.